the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

KBS eyeing over 5,000 participants for phase two of Klas Renang

KUALA LUMPUR: The Ministry of Youth and Sports (KBS) aims to attract 5,760 children aged between six and 12 to join phase two of the Basic Sports Training Skills: Swimming (KLAS Renang) programme from this month until December.

Following the encouraging response to the first phase, the KBS said that the programme, which is open specifically to children from B40 families and managed by the National Youth and Sports Department (JBSN), will be expanded to 36 more locations nationwide.

“Phase One of the KLAS Renang programme, which was launched in May 2023, received a positive reaction whereby 739 participants, comprising children aged six to 12, completed learning and training with an average of 90 per cent mastery of basic swimming skills, especially in water confidence and various swimming techniques,” the KBS said in a statement today.

It added that pre-registration for phase two of KLAS Renang has been open since Aug 16 and parents or guardians of successful candidates will be contacted by the JBSN Secretariat for further coordination.

The ministry said that the programme, in maintaining strategic cooperation with Allianz Malaysia Berhad and Nestle Products Sdn Bhd, has added new strategic partners in Decathlon (M) Sdn Bhd and Pos Malaysia Berhad.

Youth and Sports Minister Hannah Yeoh officiated the launch of phase two of KLAS Renang at the Aquatics Excellence Centre, Sarawak State Youth and Sports Complex in Kuching today.

The main objective of this initiative is to reduce the death rate due to drowning through exposure to basic swimming techniques for children in B40 families.-Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings